In a recent episode of the BioBreakthroughs podcast, host Jared S. Taylor sat down with Paul Billings, CEO of Biological Dynamics, to talk about the revolutionary advances our company is making in the field of liquid biopsies. With a strong foundation in medicine and biotechnology, Paul Billings shared how the focus on exosomes is transforming the early detection of pancreatic cancer and much more.

To watch the podcast, visit #15 - Paul Billings, CEO and Director of Biological Dynamics (sliceofhealthcare.com)